Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:5754871rdf:typepubmed:Citationlld:pubmed
pubmed-article:5754871lifeskim:mentionsumls-concept:C0021494lld:lifeskim
pubmed-article:5754871lifeskim:mentionsumls-concept:C0027145lld:lifeskim
pubmed-article:5754871lifeskim:mentionsumls-concept:C0017687lld:lifeskim
pubmed-article:5754871lifeskim:mentionsumls-concept:C0021641lld:lifeskim
pubmed-article:5754871lifeskim:mentionsumls-concept:C0017725lld:lifeskim
pubmed-article:5754871lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:5754871lifeskim:mentionsumls-concept:C1899558lld:lifeskim
pubmed-article:5754871pubmed:issue1lld:pubmed
pubmed-article:5754871pubmed:dateCreated1969-1-8lld:pubmed
pubmed-article:5754871pubmed:languageitalld:pubmed
pubmed-article:5754871pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5754871pubmed:citationSubsetIMlld:pubmed
pubmed-article:5754871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5754871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5754871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5754871pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:5754871pubmed:statusMEDLINElld:pubmed
pubmed-article:5754871pubmed:monthFeblld:pubmed
pubmed-article:5754871pubmed:issn0015-5535lld:pubmed
pubmed-article:5754871pubmed:authorpubmed-author:TamburranoGGlld:pubmed
pubmed-article:5754871pubmed:authorpubmed-author:FalluccaFFlld:pubmed
pubmed-article:5754871pubmed:authorpubmed-author:MenzingerGGlld:pubmed
pubmed-article:5754871pubmed:authorpubmed-author:AndreaniDDlld:pubmed
pubmed-article:5754871pubmed:authorpubmed-author:AlibertiGGlld:pubmed
pubmed-article:5754871pubmed:issnTypePrintlld:pubmed
pubmed-article:5754871pubmed:volume21lld:pubmed
pubmed-article:5754871pubmed:ownerNLMlld:pubmed
pubmed-article:5754871pubmed:authorsCompleteYlld:pubmed
pubmed-article:5754871pubmed:pagination18-30lld:pubmed
pubmed-article:5754871pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:5754871pubmed:meshHeadingpubmed-meshheading:5754871-...lld:pubmed
pubmed-article:5754871pubmed:meshHeadingpubmed-meshheading:5754871-...lld:pubmed
pubmed-article:5754871pubmed:meshHeadingpubmed-meshheading:5754871-...lld:pubmed
pubmed-article:5754871pubmed:meshHeadingpubmed-meshheading:5754871-...lld:pubmed
pubmed-article:5754871pubmed:meshHeadingpubmed-meshheading:5754871-...lld:pubmed
pubmed-article:5754871pubmed:meshHeadingpubmed-meshheading:5754871-...lld:pubmed
pubmed-article:5754871pubmed:meshHeadingpubmed-meshheading:5754871-...lld:pubmed
pubmed-article:5754871pubmed:meshHeadingpubmed-meshheading:5754871-...lld:pubmed
pubmed-article:5754871pubmed:year1968lld:pubmed
pubmed-article:5754871pubmed:articleTitle[Immunoreactive plasmatic insulin (IRI) in hyperthyreosis and myxedema. Effects of glucose and glucagon in intravenous injection].lld:pubmed
pubmed-article:5754871pubmed:publicationTypeJournal Articlelld:pubmed